Ensuring the safety and efficacy of pharmaceutical products is paramount in the health care industry. In this white paper, we delve into the FDA’s Quality Management Maturity Program’s benefits, the rating system's evaluation criteria, advantages for CDMOs, challenges they may encounter, and actionable steps to overcome these hurdles and achieve excellence in their quality management systems.
This content is sponsored by:
